Dr. Bailes is a globally-recognized leader in the field of neurosurgery and the impact of brain injury on brain function. He is Chairman of the Department of Neurosurgery, Co-Director of the NorthShore Neurological Institute, and Clinical Professor of Neurosurgery at the University of Chicago Pritzker School of Medicine.
Prior, Dr. Bailes was Chief of Cerebrovascular Surgery at Allegheny-West Penn Hospital System for ten years, subsequently serving for eleven years as the Professor and Chairman of the Department of Neurosurgery at West Virginia University School of Medicine where he specialized in cerebrovascular disease, stroke, brain tumors, and traumatic brain injury.
Dr. Cross is an Associate Professor, Department of Radiology and Imaging Sciences, University of Utah School of Medicine, Salt Lake City, UT; and principal investigator in the University’s NeuroImaging and Biotechnology Laboratory (NIBL) research programs in Alzheimer’s disease, traumatic brain injuries, dementia and aging.
Dr. Cross is an engineer and neuroscientist in the field of Radiology with 20 years of experience using neuroimaging to study neurodegenerative disease and CNS injuries. Her research focuses upon therapeutic and diagnostic options for neurological disorders, including the innovative use of imaging technology to provide a translational bridge between benchtop and patient, and to advance biological discovery through novel applications of imaging and data analysis. Dr. Cross is the Associate Chair for Scientific Abstracts for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and will be the President of the SNMMI Brain Imaging Council in 2022
Edward D. Hall, PhD is the William R. Markesbery, M.D. Chair in Neurotrauma Research Spinal Cord and Brain Injury Research Center, and Professor of Neuroscience, Neurology, Neurosurgery and Physical Medicine & Rehabilitation University of Kentucky Chandler Medical Center Lexington, KY.
Dr. Hall received his B.S. in biology from Mount Union College and his Ph.D. in neuropharmacology from the Cornell University Graduate School of Medical Sciences, and completed a post-doctoral fellowship at Cornell University. Initially an Associate Professor of Pharmacology at Northeastern Ohio Universities College of Medicine, he later joined The Upjohn Company where he initiated and led efforts to discover and develop agents for the treatment of traumatic brain and spinal cord injury and stroke. He joined Parke- Davis Pharmaceutical Research which became part of Pfizer Global Research and Development (PGRD) where he was appointed Senior Director of the CNS Pharmacology Program. In 2002, he joined the University of Kentucky Medical Center where he was Director of the Spinal Cord and Brain Injury Research Center (SCoBIRC) until 2012, to become the chair of neurotrauma research. Dr. Hall is an authority on the pathophysiology of acute neurological injury and he played a leading role in the discovery and development of high dose methylprednisolone therapy for acute spinal cord injury.
His ongoing research at the University of Kentucky is directed at the discovery of novel neuroprotective pharmacological strategies for acute TBI and SCI. Dr. Hall is currently a Section Editor for the Journal of Neurotrauma as well as serving, or having served, on the editorial boards of the Journal of Cerebral Blood Flow & Metabolism, Restorative Neurology and Neuroscience and Biochemical Pharmacology. In addition, he has served as a chair, a regular member or an ad hoc reviewer for several National Institute for Neurological Disorders and Stroke (NINDS) study sections, as Chair of the Veterans Administration Neurobiology C Merit Review Panel and as a member of the Paralyzed Veterans of America Spinal Cord Research Foundation Scientific Advisory Board. He also served as President of the National Neurotrauma Society from 2007-2008.
• Editorial Board, Central Nervous System Trauma. 1983-1988.
• Associate Editor, Journal of Neurotrauma. 1988-1995.
• Section Editor (Neuropharmacology and Preclinical Investigations), Journal of Neurotrauma, 1995-Present
• Editorial Board, Neurotherapeutics, 2002-Present
• Editorial Board, Biochemical Pharmacology, 2006-2010
• Editorial Board, Journal of Cerebral Blood Flow & Metabolism. 2008-2011
• International Editorial Board, The Indian Journal of Neurotrauma. 2013-Present
• Editorial Board, Alzheimer’s Disease & Dementia. 2017-Present
Dr. John “Jack” Lee is the NorthShore University HealthSystem Board of Directors/Ivan S. Ciric, MD, Chair of Neurosciences. Since 2018 Dr. Lee has served as the Editor-in-Chief for the Journal of Neuropathology and Experimental Neurology.
Dr. Lee attended Yale University, receiving his undergraduate degree in psychology in 1978. He continued his studies at the University of Illinois/Chicago earning his PhD in Physiology and Biophysics in 1983 and MD in 1988. He trained as a resident in neuropathology in Boston at Massachusetts General Hospital, Harvard Medical School. In 1992, he went to Loyola University Medical Center where he held many leadership positions there including Chairman of Pathology, Vice-President of Loyola University Medical Center and Dean of the Stritch School of Medicine. Recruited to NorthShore University Health System in 2013, he has established a Brain Bank for neurodegenerative disease and traumatic brain injury. He has served as the Residency Program Director and the Vice Chairmen for Research and Education in the Department of Pathology. Currently, he is a member American Association for the Advancement of Science, College of American Pathology and the American Association of Neuropathologists (AANP). Dr. Lee has written and lectured on the neuropathology and clinical drug development for Alzheimer’s disease as well as on traumatic brain injury (TBI), chronic traumatic encephalopathy (CTE) and has published well over 100 articles and book chapters.
Dr. Minoshima is Professor and Anne G. Osborn Chair in the Department of Radiology and Imaging Sciences at the University of Utah, and past President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
Dr. Minoshima’s many scientific contributions in the field of Neuroscience include the discovery of very early sign of Alzheimer’s disease in the posterior cingulate cortex and worldwide dissemination of diagnostic statistical mapping technology. Dr. Minoshima has held numerous and significant positions in the Society of Nuclear Medicine and Molecular Imaging (SNMMI) including serving as President of that organization) and awards, including the Tetalman Memorial Award in 1996 and Kuhl-Lassen Award in 2006; Clinical Teaching Award of the Year in 2014; and the SNMMI Presidential Distinguished Service Award in 2016. He has also received the Gold Medal Award from the American Roentgen Ray Society (ARRS).